# Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions

> **NCT01448772** · PHASE1 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 88 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Dronabinol Capsules, 5 mg
- **DRUG:** Dronabinol Oral Solution

## Key facts

- **NCT ID:** NCT01448772
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448772, "Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01448772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*